Search Results

There are 1049 results for: content related to: Drug therapy: Rifaximin 1

  1. Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 2, July 2014, Pages: 123–132, N. Kimer, A. Krag, S. Møller, F. Bendtsen and L. L. Gluud

    Article first published online : 21 MAY 2014, DOI: 10.1111/apt.12803

  2. You have full text access to this OnlineOpen article
    Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1161–1168, P. Schoenfeld, M. Pimentel, L. Chang, A. Lembo, W. D. Chey, J. Yu, C. Paterson, E. Bortey and W. P. Forbes

    Article first published online : 3 APR 2014, DOI: 10.1111/apt.12735

  3. You have free access to this content
    Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1155–1164, P. LAYER and V. ANDRESEN

    Article first published online : 11 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04296.x

  4. Rifaximin for the Treatment of Hepatic Encephalopathy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1019–1032, Dr. Kenneth R. Lawrence and Dr. Jacqueline A. Klee

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1019

  5. You have free access to this content
    Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico

    Journal of Travel Medicine

    Volume 17, Issue 2, March/April 2010, Pages: 111–117, Francisco Martinez-Sandoval, Charles D. Ericsson, Zhi-Dong Jiang, Pablo C. Okhuysen, Juan H.M. Meléndez Romero, Norma Hernandez, William P. Forbes, Audrey Shaw, Enoch Bortey and Herbert L. DuPont

    Article first published online : 24 JAN 2010, DOI: 10.1111/j.1708-8305.2009.00385.x

  6. The Effect of Multiple-Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1361–1369, Dr. Helen S. Pentikis, Dr. Margaret Connolly, Dr. Carol B. Trapnell, Dr. William P. Forbes and Dr. Doug K. Bettenhausen

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1361

  7. You have free access to this content
    Efficacy of Rifaximin in Prevention of Travelers' Diarrhea: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

    Journal of Travel Medicine

    Volume 19, Issue 6, December 2012, Pages: 352–356, Yangmin Hu, Jing Ren, Mei Zhan, Wenlu Li and Haibin Dai

    Article first published online : 14 SEP 2012, DOI: 10.1111/j.1708-8305.2012.00650.x

  8. You have free access to this content
    Rifaximin in the treatment of recurrent Clostridium difficile infection

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 1, January 2013, Pages: 122–128, E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari and V.-J. Anttila

    Article first published online : 24 OCT 2012, DOI: 10.1111/apt.12111

  9. You have free access to this content
    Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1000–1006, M. Furnari, A. Parodi, L. Gemignani, E. G. Giannini, S. Marenco, E. Savarino, L. Assandri, V. Fazio, D. Bonfanti, S. Inferrera and V. Savarino

    Article first published online : 18 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04436.x

  10. You have free access to this content
    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1147–1161, E. HUANG, E. ESRAILIAN and B. M. R. SPIEGEL

    Article first published online : 9 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03464.x

  11. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

    Sleep and Biological Rhythms

    Volume 10, Issue 2, April 2012, Pages: 145–153, Leonard B WEINSTOCK and Suzie ZEISS

    Article first published online : 4 MAR 2012, DOI: 10.1111/j.1479-8425.2012.00537.x

  12. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 8, October 2013, Pages: 925–934, S. C. Shah, L. W. Day, M. Somsouk and J. L. Sewell

    Article first published online : 4 SEP 2013, DOI: 10.1111/apt.12479

  13. You have free access to this content
    Review article: the current pharmacological therapies for hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue s1, February 2007, Pages: 23–31, N. M. BASS

    Article first published online : 23 JAN 2007, DOI: 10.1111/j.1746-6342.2006.03218.x

  14. Determination of rifaximin in rat serum by ionic liquid based dispersive liquid–liquid microextraction combined with RP-HPLC

    Journal of Separation Science

    Volume 35, Issue 15, August 2012, Pages: 1945–1952, Ramisetti Nageswara Rao, Rajavarapu Mastan Vali and Alamanda Vara Prasada Rao

    Article first published online : 2 JUL 2012, DOI: 10.1002/jssc.201200202

  15. You have free access to this content
    Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 8, August 2000, Pages: 1001–1008, M. Di Stefano, A. Strocchi, S. Malservisi, G. Veneto, A. Ferrieri and G. R. Corazza

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00808.x

  16. You have free access to this content
    Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1164–1171, Jasmohan S. Bajaj, Steven D. Pinkerton, Arun J. Sanyal and Douglas M. Heuman

    Article first published online : 27 MAR 2012, DOI: 10.1002/hep.25507

  17. You have free access to this content
    Complications of Cirrhosis

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 847A–898A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26866

  18. You have free access to this content
    Gut instinct: Rifaximin for the prevention of hepatic encephalopathy

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 792–794, Asma Siddique and Kris Kowdley

    Article first published online : 23 JUL 2010, DOI: 10.1002/hep.23822

  19. You have free access to this content
    Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 5, May 2000, Pages: 551–556, Di Stefano, Malservisi, Veneto, Ferrieri and Corazza

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00751.x

  20. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 3, March 2013, Pages: 450–455, Jiannis Vlachogiannakos, Nikos Viazis, Panagiota Vasianopoulou, Irene Vafiadis, Dimitrios G Karamanolis and Spiros D Ladas

    Article first published online : 26 FEB 2013, DOI: 10.1111/jgh.12070